
Stevanato Group Investor Relations Material
Latest events

Q2 2025
Stevanato Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Stevanato Group S.p.A.
Access all reports
Stevanato Group S.p.A. is a global provider of containment, delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries. The company specializes in the production of glass containers, such as vials, syringes, and cartridges, used for drug storage and delivery. In addition to its core manufacturing services, Stevanato offers integrated solutions that include drug delivery systems, assembly equipment, and analytical testing. Its products support a range of applications, including injectable drugs, biologics, and diagnostics, helping ensure the safe and effective administration of treatments. The company is headquartered in Piombino Dese, Italy, and its shares are listed on the NYSE.
Key slides for Stevanato Group S.p.A.


Q1 2025
Stevanato Group S.p.A.


Q2 2025
Stevanato Group S.p.A.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
STVN
Country
🇺🇸 United States